Immune Profile and Mitotic Index of Metastatic Melanoma Lesions Enhance Clinical Staging in Predicting Patient Survival

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0905139106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Extrapolating Survival in a Heterogeneous Patient Population With Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Late Development of Splenic Sarcoidosis-Like Lesions in a Patient With Metastatic Melanoma and Long-Lasting Clinical Response to Ipilimumab

OncoImmunology
OncologyAllergyImmunology
2014English

Discordancy in BRAF Mutations Among Primary and Metastatic Melanoma Lesions: Clinical Implications for Targeted Therapy

Modern Pathology
Forensic MedicinePathology
2014English

Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Immune Correlates of Melanoma Survival in Adoptive Cell Therapy

OncoImmunology
OncologyAllergyImmunology
2013English

Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab

Journal of Cutaneous Immunology and Allergy
2019English

Metastatic Melanoma: Prognostic Factors and Survival in Patients With Brain Metastases

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Increased Survival Time of a Patient With Metastatic Malignant Melanoma Following Immunotherapy: A Case Report and Literature Review

Oncology Letters
Cancer ResearchOncology
2015English

Predicting PICU Patient Survival Prognosis: Pediatric Logistic Organ Dysfunction vs Pediatric Index of Mortality Scores

Paediatrica Indonesiana
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy